home / stock / apdn / apdn news


APDN News and Press, Applied DNA Sciences Inc. From 05/29/25

Stock Information

Company Name: Applied DNA Sciences Inc.
Stock Symbol: APDN
Market: NASDAQ
Website: adnas.com

Menu

Get APDN Alerts

News, Short Squeeze, Breakout and More Instantly...

APDN - Applied DNA announces 1-for-15 reverse stock split

2025-05-29 08:23:08 ET More on Applied DNA Sciences Applied DNA regains compliance with Nasdaq minimum bid price rule Applied DNA announces 1-for-50 reverse stock split Seeking Alpha’s Quant Rating on Applied DNA Sciences Read the full article on See...

APDN - Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-15 reverse stock split of its issued and outstanding common stock. The Reverse Sto...

APDN - Applied DNA Sciences GAAP EPS of -$15.35, revenue of $0.98M misses by $0.21M

2025-05-15 16:46:54 ET More on Applied DNA Sciences Applied DNA regains compliance with Nasdaq minimum bid price rule Applied DNA announces 1-for-50 reverse stock split Seeking Alpha’s Quant Rating on Applied DNA Sciences Historical earnings data for A...

APDN - Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

- Therapeutic DNA Production Services Segment (LineaRx) Revenues Up 44% Y/Y, Contributing to a 6% Increase in Total Revenues - - Intra-Quarter Investor Conference Call and Webcast Scheduled for June 3, 2025, at 4:30 PM ET - STONY BROOK, NY / ACCESS Newswire / May 15, 2025 / App...

APDN - Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

STONY BROOK, NY / ACCESS Newswire / May 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, will release its financial results for the second quarter of fiscal year 2025 (ended on March 31, 2025...

APDN - Healthcare stocks that could be poised for a rebound

2025-05-09 12:31:58 ET More on Health Care Select Sector SPDR® Fund ETF: XLV Vs. VHT: I Prefer XLV For Its Better Downturn Resilience XLV: My Method For Navigating These Pullbacks India proposes zero-for-zero tariff deal on U.S. auto parts, steel - report ...

APDN - APDN - Historical Price Movements Surrounding Earnings

2025-05-08 18:48:19 ET Applied DNA Sciences, Inc. (APDN) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 7.04%. The average open to low on the day of earnings was -7.06%. The average ope...

APDN - APDN - Historical Earnings Price Analysis

2025-05-08 18:43:19 ET Applied DNA Sciences, Inc. (APDN) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in APDN stock price following earnings has averaged ±6.22% , with a median of 4.00...

APDN - Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

- Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that LineaRx, Inc., the Compa...

APDN - Applied DNA regains compliance with Nasdaq minimum bid price rule

2025-04-08 09:14:19 ET More on Applied DNA Sciences Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call Transcript Applied DNA announces 1-for-50 reverse stock split WHO maintains public health emergency alert on mpox Seeking Alpha’s Quant Rating o...

Previous 10 Next 10